<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02152917</url>
  </required_header>
  <id_info>
    <org_study_id>2014/11297</org_study_id>
    <nct_id>NCT02152917</nct_id>
  </id_info>
  <brief_title>Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty</brief_title>
  <official_title>Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty - Randomized Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The total knee arthroplasty (TKA) is a well established option for the treatment of
      osteoarthritis in this joint. Nevertheless, there are still some concerns related to the
      peri-operative management of elderly patients, highlighting the complications related to
      medical comorbidity and bleeding produced by surgery. One of the proposed methods to decrease
      postoperative bleeding, which has been accumulating favorable evidence, is the use of
      tranexamic acid (TA). Several studies (including prospective randomized trials with placebo
      group) showed excellent results with TA intravenous administration during TKA, reducing the
      amount of bleeding, the drop in hemoglobin and the need for blood transfusion. Another
      alternative to minimize bleeding is the use of topical hemostatic agent Floseal®, composed of
      thrombin and bovine gelatin. This substance has presented significant benefits on bleeding
      control in several areas of medicine, including orthopedic surgery, but no action has yet
      been established in TKA. The main objective is to evaluate the amount of bleeding, the drop
      in hemoglobin and the need for blood transfusion after TKA, comparing the use of TA, Floseal®
      and a control group. The secondary objective is to evaluate the rate of adverse events in the
      studied groups.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of bleeding</measure>
    <time_frame>First two days post-operative</time_frame>
    <description>Measure of the drain volume on the first two days post-operative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Drop in hemoglobin</measure>
    <time_frame>Three days postoperative</time_frame>
    <description>Difference between the preoperative hemoglobin and hemoglobin in the third postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Tranexamic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A dose of tranexamic acid (10mg/Kg) will be administered 20 minutes before inflating the pneumatic tourniquet and another dose 15 minutes after the tourniquet release.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Floseal®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Floseal® will be applied in regions of potential bleeding before the release of the pneumatic tourniquet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic acid</intervention_name>
    <arm_group_label>Tranexamic acid</arm_group_label>
    <other_name>TA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Floseal®</intervention_name>
    <arm_group_label>Floseal®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for total knee arthroplasty

          -  No previous knee surgery

          -  Absence of inflammatory arthritis

          -  Absence of stiff knee

          -  Absence of the following factors: renal failure, liver failure, severe heart failure,
             respiratory failure, history of thromboembolic events, bleeding disorders, previous
             strokes

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camilo P Helito, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ricardo G Gobbi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis Eduardo P Tirico, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco K Demange, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose R Pecora, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilberto L Camanho, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcelo B Bonadio, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tania Fernanda, B.A.</last_name>
    <phone>+55 11 976515344</phone>
    <email>taniafernanda@terra.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital das Clinicas - University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tania Fernanda, B.A.</last_name>
      <phone>+55 11 976515344</phone>
      <email>taniafernanda@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Camilo P Helito, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2014</study_first_posted>
  <last_update_submitted>May 30, 2014</last_update_submitted>
  <last_update_submitted_qc>May 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Marco Kawamura Demange</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

